Utah Medical Device Manufacturer Partners with PollenSense to Produce Innovative Allergy Monitoring Technology

A strategic manufacturing partnership between Turner MedTech and PollenSense promises to deliver advanced pollen monitoring technology to market, offering hope for individuals struggling with seasonal allergies. The collaboration aims to produce a sophisticated sensor-based device capable of providing real-time, hyperlocal pollen count information.

The PollenSense device represents a significant advancement in environmental health monitoring, utilizing cutting-edge sensor technology to detect and report precise pollen levels. By offering more accurate and immediate data than traditional monitoring methods, the device could help allergy sufferers better manage their symptoms and make informed decisions about outdoor activities.

Turner MedTech, an ISO 13485 certified medical device contract manufacturer, will leverage its extensive engineering expertise to bring the PollenSense technology into production. The partnership is expected to create new employment opportunities in Utah and contribute to the state's growing medical technology sector.

According to company leadership, the device will enter production in the second quarter of 2025, with plans to address a significant market need. Approximately 50 million Americans suffer from allergies annually, making the PollenSense technology potentially transformative for individuals seeking more proactive health management strategies.

The collaboration highlights the continued innovation in medical technology, demonstrating how specialized manufacturing partnerships can rapidly advance solutions to complex health challenges. By combining PollenSense's innovative sensor technology with Turner MedTech's manufacturing capabilities, the partnership represents a promising approach to developing targeted health monitoring solutions.